Garrido MA - Search Results

1

Human peripheral blood lymphocytes targeted with bispecific antibodies release cytokines that are essential for inhibiting tumor growth.

Qian JH, Titus JA, Andrew SM, Mezzanzanica D, Garrido MA, Wunderlich JR, Segal DM. Qian JH, et al. Among authors: garrido ma. J Immunol. 1991 May 1;146(9):3250-6. J Immunol. 1991. PMID: 1826709

2

Targeting of anti-tumor responses with bispecific antibodies.

Segal DM, Qian JH, Mezzanzanica D, Garrido MA, Titus JA, Andrew SM, George AJ, Jost CR, Perez P, Wunderlich JR. Segal DM, et al. Among authors: garrido ma. Immunobiology. 1992 Aug;185(2-4):390-402. doi: 10.1016/S0171-2985(11)80655-8. Immunobiology. 1992. PMID: 1452212 Review.

3

Bispecific antibodies and retargeted cellular cytotoxicity: novel approaches to cancer therapy.

Wunderlich JR, Mezzanzanica D, Garrido MA, Neblock DS, Daddona PE, Andrew SM, Zurawski VR Jr, Canevari S, Colnaghi MI, Segal DM. Wunderlich JR, et al. Among authors: garrido ma. Int J Clin Lab Res. 1992;22(1):17-20. doi: 10.1007/BF02591388. Int J Clin Lab Res. 1992. PMID: 1633315

4

Targeted cytotoxic cells in human peripheral blood lymphocytes.

Garrido MA, Perez P, Titus JA, Valdayo MJ, Winkler DF, Barbieri SA, Wunderlich JR, Segal DM. Garrido MA, et al. J Immunol. 1990 Apr 15;144(8):2891-8. J Immunol. 1990. PMID: 1691221

5

Cytokine release by peripheral blood lymphocytes targeted with bispecific antibodies, and its role in blocking tumor growth.

Segal DM, Qian JH, Andrew SM, Titus JA, Mezzanzanica D, Garrido MA, Wunderlich JR. Segal DM, et al. Among authors: garrido ma. Ann N Y Acad Sci. 1991 Dec 30;636:288-94. doi: 10.1111/j.1749-6632.1991.tb33459.x. Ann N Y Acad Sci. 1991. PMID: 1793216 Review. No abstract available.

6

Human T-lymphocytes targeted against an established human ovarian carcinoma with a bispecific F(ab')2 antibody prolong host survival in a murine xenograft model.

Mezzanzanica D, Garrido MA, Neblock DS, Daddona PE, Andrew SM, Zurawski VR Jr, Segal DM, Wunderlich JR. Mezzanzanica D, et al. Among authors: garrido ma. Cancer Res. 1991 Oct 15;51(20):5716-21. Cancer Res. 1991. PMID: 1833054

7

Targeting human T-lymphocytes with bispecific antibodies to react against human ovarian carcinoma cells growing in nu/nu mice.

Garrido MA, Valdayo MJ, Winkler DF, Titus JA, Hecht TT, Perez P, Segal DM, Wunderlich JR. Garrido MA, et al. Cancer Res. 1990 Jul 15;50(14):4227-32. Cancer Res. 1990. PMID: 2142014

8

Refocusing the immune system to react with human tumors by targeting human lymphocytes with bispecific antibodies.

Garrido MA, Valdayo MJ, Winkler DF, Titus JA, Hecht TT, Perez P, Segal DM, Wunderlich JR. Garrido MA, et al. Dev Biol Stand. 1990;71:33-42. Dev Biol Stand. 1990. PMID: 2144834

9

Effectors of targeted cellular cytotoxicity.

Segal DM, Garrido MA, Qian JH, Mezzanzanica D, Andrew S, Perez P, Kurucz I, Valdayo MJ, Titus JA, et al. Segal DM, et al. Among authors: garrido ma. Mol Immunol. 1990 Dec;27(12):1339-42. doi: 10.1016/0161-5890(90)90040-7. Mol Immunol. 1990. PMID: 2274063 Review. No abstract available.

10

Human K/natural killer cells targeted with hetero-cross-linked antibodies specifically lyse tumor cells in vitro and prevent tumor growth in vivo.

Titus JA, Perez P, Kaubisch A, Garrido MA, Segal DM. Titus JA, et al. Among authors: garrido ma. J Immunol. 1987 Nov 1;139(9):3153-8. J Immunol. 1987. PMID: 2959724

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters